Anti-CD19 chimeric antigen receptor T-cell therapy in a highly sensitized patient with focal and segmental glomerulosclerosis.

Explores the cutting-edge use of CAR-T cell therapies to overcome immunological barriers in highly sensitized kidney transplant candidates.